167 related articles for article (PubMed ID: 34788830)
1. Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.
Schröder MAM; van Herwaarden AE; Span PN; van den Akker ELT; Bocca G; Hannema SE; van der Kamp HJ; de Kort SWK; Mooij CF; Schott DA; Straetemans S; van Tellingen V; van der Velden JA; Sweep FCGJ; Claahsen-van der Grinten HL
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1661-e1672. PubMed ID: 34788830
[TBL] [Abstract][Full Text] [Related]
2. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
3. Diurnal salivary androstenedione and 17-hydroxyprogesterone levels in healthy volunteers for monitoring treatment efficacy of patients with congenital adrenal hyperplasia.
Adriaansen BPH; Kamphuis JS; Schröder MAM; Olthaar AJ; Bock C; Brandt A; Stikkelbroeck NMML; Lentjes EGWM; Span PN; Sweep FCGJ; Claahsen-van der Grinten HL; van Herwaarden AE
Clin Endocrinol (Oxf); 2022 Jul; 97(1):36-42. PubMed ID: 35150157
[TBL] [Abstract][Full Text] [Related]
4. Crinecerfont, a CRF1 Receptor Antagonist, Lowers Adrenal Androgens in Adolescents With Congenital Adrenal Hyperplasia.
Newfield RS; Sarafoglou K; Fechner PY; Nokoff NJ; Auchus RJ; Vogiatzi MG; Jeha GS; Giri N; Roberts E; Sturgeon J; Chan JL; Farber RH
J Clin Endocrinol Metab; 2023 Oct; 108(11):2871-2878. PubMed ID: 37216921
[TBL] [Abstract][Full Text] [Related]
5. Crinecerfont Lowers Elevated Hormone Markers in Adults With 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.
Auchus RJ; Sarafoglou K; Fechner PY; Vogiatzi MG; Imel EA; Davis SM; Giri N; Sturgeon J; Roberts E; Chan JL; Farber RH
J Clin Endocrinol Metab; 2022 Feb; 107(3):801-812. PubMed ID: 34653252
[TBL] [Abstract][Full Text] [Related]
6. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry.
Lawrence N; Bacila I; Dawson J; Bryce J; Ali SR; van den Akker ELT; Bachega TASS; Baronio F; Birkebaek NH; Bonfig W; van der Grinten HC; Costa EC; de Vries L; Elsedfy H; Güven A; Hannema S; Iotova V; van der Kamp HJ; Clemente M; Lichiardopol CR; Milenkovic T; Neumann U; Nordenström A; Poyrazoğlu Ş; Probst-Scheidegger U; De Sanctis L; Tadokoro-Cuccaro R; Thankamony A; Vieites A; Yavaş Z; Faisal Ahmed S; Krone N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):551-561. PubMed ID: 35781728
[TBL] [Abstract][Full Text] [Related]
7. Salivary Profiles of 11-oxygenated Androgens Follow a Diurnal Rhythm in Patients With Congenital Adrenal Hyperplasia.
Nowotny HF; Auer MK; Lottspeich C; Schmidt H; Dubinski I; Bidlingmaier M; Adaway J; Hawley J; Keevil B; Reisch N
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4509-e4519. PubMed ID: 34165575
[TBL] [Abstract][Full Text] [Related]
8. Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoid therapy.
German A; Suraiya S; Tenenbaum-Rakover Y; Koren I; Pillar G; Hochberg Z
J Clin Endocrinol Metab; 2008 Dec; 93(12):4707-10. PubMed ID: 18782876
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.
Verma S; Vanryzin C; Sinaii N; Kim MS; Nieman LK; Ravindran S; Calis KA; Arlt W; Ross RJ; Merke DP
Clin Endocrinol (Oxf); 2010 Apr; 72(4):441-7. PubMed ID: 19486026
[TBL] [Abstract][Full Text] [Related]
10. Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia.
Winterer J; Chrousos GP; Loriaux DL; Cutler GB
J Pediatr; 1985 Jan; 106(1):137-42. PubMed ID: 3871229
[TBL] [Abstract][Full Text] [Related]
11. Daily profiles of salivary cortisol in hydrocortisone treated children with congenital adrenal hyperplasia.
Hampl R; Foretová L; Sulcová J; Stárka L
Eur J Pediatr; 1990 Jan; 149(4):232-4. PubMed ID: 2303071
[TBL] [Abstract][Full Text] [Related]
12. Relationships of basal level of serum 17-hydroxyprogesterone with that of serum androstenedione and their stimulated responses to a low dose of ACTH in young adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kang MJ; Kim SM; Lee YA; Shin CH; Yang SW
J Korean Med Sci; 2011 Nov; 26(11):1454-60. PubMed ID: 22065901
[TBL] [Abstract][Full Text] [Related]
13. Cortisol and 17-hydroxyprogesterone kinetics in saliva after oral administration of hydrocortisone in children and young adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Gröschl M; Rauh M; Dörr HG
J Clin Endocrinol Metab; 2002 Mar; 87(3):1200-4. PubMed ID: 11889188
[TBL] [Abstract][Full Text] [Related]
14. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements.
Hughes IA; Read GF
Horm Res; 1984; 19(2):77-85. PubMed ID: 6538545
[TBL] [Abstract][Full Text] [Related]
15. First Morning Pregnanetriol and 17-Hydroxyprogesterone Correlated Significantly in 21-Hydroxylase Deficiency.
Itonaga T; Izawa M; Hamajima T; Hasegawa Y
Front Endocrinol (Lausanne); 2021; 12():808254. PubMed ID: 35140686
[TBL] [Abstract][Full Text] [Related]
16. Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency.
Turcu AF; Spencer-Segal JL; Farber RH; Luo R; Grigoriadis DE; Ramm CA; Madrigal D; Muth T; O'Brien CF; Auchus RJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):1174-80. PubMed ID: 26751191
[TBL] [Abstract][Full Text] [Related]
17. Androgen excess is due to elevated 11-oxygenated androgens in treated children with congenital adrenal hyperplasia.
Kamrath C; Wettstaedt L; Boettcher C; Hartmann MF; Wudy SA
J Steroid Biochem Mol Biol; 2018 Apr; 178():221-228. PubMed ID: 29277706
[TBL] [Abstract][Full Text] [Related]
18. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE
J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
[TBL] [Abstract][Full Text] [Related]
19. Abiraterone acetate to lower androgens in women with classic 21-hydroxylase deficiency.
Auchus RJ; Buschur EO; Chang AY; Hammer GD; Ramm C; Madrigal D; Wang G; Gonzalez M; Xu XS; Smit JW; Jiao J; Yu MK
J Clin Endocrinol Metab; 2014 Aug; 99(8):2763-70. PubMed ID: 24780050
[TBL] [Abstract][Full Text] [Related]
20. Hormonal circadian rhythms in patients with congenital adrenal hyperplasia: identifying optimal monitoring times and novel disease biomarkers.
Debono M; Mallappa A; Gounden V; Nella AA; Harrison RF; Crutchfield CA; Backlund PS; Soldin SJ; Ross RJ; Merke DP
Eur J Endocrinol; 2015 Dec; 173(6):727-37. PubMed ID: 26340969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
